DMST solution
CAS: 66840-71-9
Rif. 3D-RCA84071
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
2500mg | Fuori produzione |
Informazioni sul prodotto
- 1-(Dimethylsulfamoylamino)-4-methylbenzene
- 4-Dimethylaminosulfotoluidide
- N,N-Dimethyl-N′-(4-methylphenyl)sulfamide
- N,N-dimethyl-N'-(4-methylphenyl)sulfuric diamide
- N,N-dimethyl-N′-p-tolylsulfamide
- Sulfamide, N,N-dimethyl-N′-(4-methylphenyl)-
- Sulfamide, N,N-dimethyl-N′-p-tolyl-
- N,N-Dimethyl-N'-p-tolylsulphamide
- DMST
DMST is a solution that is used for the treatment of oral pathogens. It has been shown to inhibit protein synthesis in the body by binding to ribosomes. DMST has also been shown to have an effect on thermal expansion, as it can be used as a matrix for laser ablation. DMST may also be effective in treating bacterial infections within the human body, as it has been shown to bind to and kill bacteria. DMST is currently being researched for its potential uses in wastewater treatment and glycemic parameters. The use of probiotic bacteria with DMST could produce a synergistic effect on the effectiveness of both antibiotics and probiotics. This could make this drug more clinically relevant, because it would be less likely to cause microbial resistance or toxicity issues.